In this blog, APhA CEO Michael Hogue urges pharmacists to pursue oncology specialization as cancer therapies become increasingly complex. He emphasizes that the next decade in oncology will be shaped not only by new therapies, but by the pharmacists who help patients make the most of them.

APhA CEO Michael Hogue urges Congress to pass the ECAPS Act to prevent the collapse of community health access — warning that continued inaction will leave vulnerable patients without essential pharmacy care.

In this blog, APhA CEO Michael Hogue reflects on the evolving nature of science and APhA’s role in championing evidence-based practice.

APhA CEO Michael Hogue makes the case for why direct-to-consumer drug programs must include pharmacists’ care — and why leaving them out would be a costly mistake.